Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Barclays PLC | BCY2 | Nov 19, 2024 | 12.20 | 0.00 |
Barclays PLC | BCY | Nov 19, 2024 | 3.05 | -2.24 |
Barco NV | BC1P | Nov 19, 2024 | 10.62 | -2.03 |
Bard1 Life Sciences Limited | EGQ0 | Nov 19, 2024 | 0.28 | +2.21 |
Barings BDC Inc | TRY | Nov 19, 2024 | 9.31 | +0.11 |
Barito Pacific TBK | OB8 | Nov 19, 2024 | 0.04 | 0.00 |
Barkby Group Plc | 3WY | Nov 19, 2024 | 0.32 | 0.00 |
BARKSDALE RES CORP Ordinary Shares | 2NZ | Nov 19, 2024 | 0.08 | +1.32 |
Barloworld Ltd | BRL1 | Nov 19, 2024 | 4.62 | +1.76 |
Barnes & Noble Education, Inc | 2BN | Nov 19, 2024 | 0.08 | 0.00 |
Barnes Group, Inc. | BG4 | Nov 19, 2024 | 43.20 | +0.93 |
Baron Oil Plc | GHA | Nov 19, 2024 | 0.00 | 0.00 |
Baroyeca Gold & Silver Inc | 8BY1 | Nov 19, 2024 | 0.00 | 0.00 |
Barratt Developments PLC | 3BA | Nov 19, 2024 | 4.74 | -0.88 |
BARRATT DEVS PLC | 3BAA | Nov 19, 2024 | 8.65 | -0.57 |
Barrett Business Services, Inc. | BB1 | Nov 19, 2024 | 38.40 | -0.52 |
Barrick Gold Corp. | ABR | Nov 19, 2024 | 16.70 | +3.93 |
Barry Callebaut AG ADR Unsponsored (Switzerland) | BCLM | Nov 19, 2024 | 14.00 | -0.71 |
BARTON GOLD HOLDINGS | BGD3 | Nov 19, 2024 | 0.17 | 0.00 |
Basf SE | BASA | Nov 19, 2024 | 10.60 | -2.75 |
Basf SE | BAS | Nov 19, 2024 | 42.50 | -1.39 |
Basic-Fit N.V | B4F | Nov 19, 2024 | 21.60 | -4.59 |
BasicNet SpA | BCJ | Nov 19, 2024 | 6.82 | -0.29 |
Basin Uranium Corp. | 6NP | Nov 19, 2024 | 0.16 | -0.31 |
Basler AG | BSL | Nov 19, 2024 | 5.38 | -2.18 |
BASSAC | 78Y | Nov 19, 2024 | 45.10 | +0.45 |
Bastei Luebbe AG | BST | Nov 19, 2024 | 9.60 | +3.23 |
Bastide Le Confort Medical | 1DJ | Nov 19, 2024 | 18.62 | -3.22 |
BASTION MINERALS LTD | J57 | Nov 19, 2024 | 0.00 | -14.29 |
Bastogi Spa | BAOA | Nov 19, 2024 | 0.40 | +2.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.